InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Patolawala Monish D, 首席财务官. Director active across 3 companies, notably 3M CO. Aggregated, 19 disclosures have been logged. Activity tracked since 1 July 2021. The latest transaction was disclosed on 3 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Patolawala Monish D
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
6,720 股@ US$79.270.0013% mcap10.2% 占其流量Common StockSEC:0001225208-26-006954:0
1,505 股Common StockSEC:0000875045-26-000059:0
40,000 股0Common StockSEC:0001225208-26-001979:0
34,447 股@ US$67.3148.1% 占其流量Common StockSEC:0001225208-26-001189:0
25,236 股@ US$54.1856.7% 占其流量Common StockSEC:0001225208-25-006940:0
2,370 股0Common StockSEC:0001127602-25-017765:0
60,819 股0Common StockSEC:0001225208-25-001773:0
18,312 股@ US$51.23100.0% 占其流量Common StockSEC:0001225208-25-001213:0
211,310 股0Common StockSEC:0001225208-24-007805:0
30,131 股@ US$102.1942.7% 占其流量Common StockSEC:0001127602-24-019536:0
1,340 股0Common StockSEC:0001127602-24-019236:0
4,089 股0Common StockSEC:0001127602-24-005166:0
10,196.16 股0Common StockSEC:0001127602-24-003517:0
4,146 股0Common StockSEC:0001127602-24-003517:1
6,128 股@ US$94.877.9% 占其流量Common StockSEC:0001127602-24-003318:0
6,013 股@ US$100.098.2% 占其流量Common StockSEC:0001127602-23-019788:0
12,626.042 股0Common StockSEC:0001127602-23-004033:0
6,013 股@ US$128.4911.2% 占其流量Common StockSEC:0001127602-22-018859:0
6,013 股@ US$199.0917.6% 占其流量Common StockSEC:0001127602-21-021521:0
19 条申报中的 19 条
About Patolawala Monish D
Patolawala Monish D is Directeur Financier. He has 18 filings in total, all covered by the available sample, and the recent filings span from 2021-07-06 to 2026-06-11. The buy and sell volumes are both 0 EUR, and the modal transaction nature is Attribution. The associated companies are 3M CO, Archer-Daniels-Midland Co and BIOGEN INC.
